HK Stock Market Move | METIS TECHBIO-P (07666) surged over 16% in early trading as its self-developed AiTEM artificial intelligence formulation platform was implemented by Jiangsu Hengrui Pharmaceuticals.

METIS TECHBIO-P (07666) surged over 16% in early trading, and as of the time of this report, it is up 15.74% at HKD 12.87, with a trading volume of HKD 13.0047 million. On the news front, Jitai Technology recently announced that its self-developed AiTEM artificial intelligence formulation innovation platform will be locally deployed at Jiangsu Hengrui Pharmaceuticals to accelerate the efficiency of drug formulation development. It is reported that AiTEM has previously empowered Jitai Technology's self-developed pipeline MTS-004 to shorten the preclinical formulation optimization cycle from the industry average of 1-2 years to completion within 3 months. China Securities Co., Ltd. released a research report stating that Jiangsu Hengrui Pharmaceuticals, as a leading company in innovative drugs, will embed the AiTEM technology platform into its core research and development system, aiming to enhance the application capabilities of AI in the formulation innovation process and strengthen the infrastructure for innovative drug development. This collaboration marks a critical shift for Jitai Technology's AiTEM platform from an internal pipeline optimization tool to an external commercialized product, promoting the ongoing deepening of the company's "platform cooperation + product cooperation" dual-driving business model, and accelerating the release of the company's platform value and commercialization realization.